Generic for Danocrine for Hormonal treatment - Drug Information

Generic Name - Danazol

Category - Endometriosis

Indications

Hormonal treatment
Generic Danocrine is indicated in a hormonal treatment which shrinks the abnormal endometrial tissue, by suppressing the hormones that cause the endometrial tissue to grow and thicken each month. Every month the endometrium, (the inner lining of a woman's uterus)is shed as the menstrual period. In women who have endometriosis, cells forming the endometrium grow outside the uterus, particularly on the ovaries. This tissue responds to the normal hormonal changes a woman experiences each month. Because this tissue cannot be shed as part of the menstrual fluid, it results in pain and possibly contributes to infertility.

Generic for Danocrine Contraindications and Drug Interactions

Generic Danocrine is contraindicated in patients, who are hypersensitive to this drug, medications that belong to this class of drugs or had an allergic reaction to it in the past.
Generic Danocrine should not be taken by patients who have a history of the following ailment conditions.

Undiagnosed abnormal genital bleeding
Liver, heart or kidney problems
Past liver problems due to oral contraceptives
Undiagnosed lumps or masses in the ovaries or womb
Pelvic infection
Cancer of womb, ovaries, cervix, vagina or breasts
High blood pressure
Porphyria which is a rare disease of blood pigments
Previous or present blockage of a blood vessel by a blood clot
Polycythemia (too many red blood cells)

There are a number of medications that interact with Generic Danocrine.It is important to take the doctor's counsel if you are taking any of the following.

Agents that dissolve blood clots
Aspirin or aspirin-like medicines
'Blood thinners' such as warfarin or heparin
Carbamazepine
Clopidogrel
Cyclosporine
Lovastatin
Medicines for diabetes
Sirolimus
Tacrolimus
Ticlopidine
Went yeast (cholestin)

Generic for Danocrine Dosage

The following information just highlights the general average dosage of GenericDanocrine
The usual recommended dosage of Generic Danocrine for Endometriosis is 400 mg b.i.d. (moderate to severe) or 100-200 mg b.i.d. (mild) for 3-6 months.

Generic for Danocrine Adverse Effects

Some of the most serious Generic Danocrine side Effects include changes in vision,
Changes in ovulation, dark yellow or brown urine, decrease in breast size, difficulty passing urine or blood in the urine, hair loss or unusual hair growth (such as facial hair growth in women),headache, irregular vaginal bleeding, and nausea.

This is not a complete list of all Side effects. Do concur with your doctor and follow his directions completely when you are taking Generic Danocrine.

Generic for Danocrine and Pregnancy

Generic Danocrine must not be taken during pregnancy. It is important that you are not pregnant before you start taking Generic Danocrine. To ensure that you are not pregnant, you should start taking Generic Danocrine whilst you are menstruating.

Generic for Danocrine and Breastfeeding

Breast-feeding is not recommended while you are taking Generic Danocrine because it may cause unwanted effects in the baby. It is not known if Generic Danocrine is found in breast milk or whether it can harm your baby.

Generic for Danocrine and Pediatric

Generic Danazol may cause male-like changes in female children and cause premature sexual development in male children. It may also slow or stop growth in any child.

Generic for Danocrine and Geriatric

There is no specific information comparing use of Generic Danazol in the elderly with use in other age groups, Generic Danazol has effects similar to androgens (male hormones). Androgens used in older males may increase the risk of developing prostate enlargement or cancer. Do talk to your doctor and obtain medical advice.

Note

The above information about Generic Danocrine serves as an information resource only and is not intended to substitute professional medical advice, examination, diagnosis and treatment.Always seek the counsel of your doctor, physician or pharmacist before starting any new treatment or making changes to existing therapy.